[Asia Economy Reporter Hwang Junho] Hyundai Pharm announced on the 21st that following the resignation of Co-CEO Kim Younghak on the 16th due to personal reasons, the company will shift to a sole CEO system under Lee Sangjun.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing